Rocket


Overview
Financials
News + Filings





Income Statement
Cash Flow Statement

InMed Pharmaceuticals Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-19Jun-30-18
   S-1/AS-1/A
Revenues  0.00.0
Cost of goods sold  0.00.0
Gross profit  0.00.0
Selling, general and administrative   [+]4.36.1
Other operating expenses  4.81.9
EBITDA   [+]-9.1-7.9
Depreciation and amortization  0.10.1
EBIT   [+]-9.2-8.0
Other income (expense), net   [+]0.0 
Pre-tax income  -9.2-8.0
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -9.2-8.0
   
Basic EPS   [+]($1.78)($1.86)
Diluted EPS   [+]($1.78)($1.86)
   
Shares outstanding (basic)   [+]5.24.3
Shares outstanding (diluted)   [+]5.24.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy